<DOC>
	<DOCNO>NCT02440672</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness JOURNEY™ II CR Total Knee System subject degenerative joint disease ( DJD ) require primary total knee replacement .</brief_summary>
	<brief_title>JOURNEY™ II CR Total Knee System</brief_title>
	<detailed_description>This prospective , non-randomized , single cohort , multicenter study evaluate clinical outcome TKA use JOURNEY™ II CR Total Knee System subject degenerative joint disease ( DJD ) require primary total knee replacement . One hundred seventy ( 170 ) subject enrol 18 clinical site globally . Follow-up clinical assessment perform 3 month , 1 year , 2 year , 5 year , 10 year post-operatively .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Subjects MUST meet ALL follow criterion inclusion study : Has sign IRB/EC approve ICF specific study prior study participation Is male female ≥ 22 ≤ 75 year age present degenerative joint disease ( DJD ) knee Is candidate primary total knee arthroplasty JOURNEY™ II CR Total Knee System due DJD , define one following : Posttraumatic arthritis Osteoarthritis Degenerative arthritis Is able read understand approve Informed Consent Form Patient Reported Outcome ( PRO ) assessment ( write oral ) Is general good health ( determined Investigator ) base screen assessment medical history Is independent , ambulatory , comply postoperative evaluation plan available ten ( 10 ) year postoperative followup Subjects exclude study , meet ANY one ( 1 ) follow criterion : Any following condition index joint : require patella resurface receive TKA unicondylar arthroplasty inadequate bone stock support device ( e.g . severe osteopenia/osteoporosis ) Any follow condition contralateral joint : enrol study contralateral knee receive TKA revision fail total unicondylar knee arthroplasty receive primary TKA unicondylar knee arthroplasty fully heal wellfunctioning , determine Investigator Any follow condition hip : receive contralateral ipsilateral revision hip arthroplasty ipsilateral hip arthritis result flexion contracture receive ipsilateral contralateral primary total hip arthroplasty hip resurface arthroplasty , fully heal wellfunctioning , determine Investigator Has diagnosis immunosuppressive disorder Has presence malignant tumor , metastatic , neoplastic disease Has family history severe osteoporosis/osteopenia Has know allergy study device one component Has condition may interfere TKA survival outcome ( e.g . Paget 's Charcot 's disease , vascular insufficiency , lupus , muscular atrophy , uncontrolled diabetes , moderate severe renal insufficiency neuromuscular disease ) Is receive medication diagnosis fibromyalgia low extremity condition cause abnormal restrict ambulation ( e.g . ankle fusion , ankle arthroplasty , previous hip fracture ) Is pregnant plan become pregnant study Has emotional neurological condition would preempt ability willingness participate study complete PROs , determine Investigator Has BMI &gt; 40 Is currently enrol participate another investigational drug , biologic , device study within 3 month enrollment Is currently involve personal injury litigation worker 's compensation claim Is face current impending incarceration Is know risk lose followup , failure return schedule visit</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>TKA</keyword>
	<keyword>Degenerative Knee Disease</keyword>
</DOC>